This study explores the role of nuclear factor interleukin 3 (Nfil3) in metabolic dysfunction-associated fatty liver disease (MASLD) development, revealing sex-specific effects and gut microbiota influence on bile acid metabolism. Here, NFIL3 is linked to metabolic dysfunction-associated steatotic liver disease.